Crossmark

Non-traumatic splenic rupture after discontinuation of zanubrutinib and venetoclax therapy in relapsed/refractory diffuse large B-cell lymphoma

Published Online: 2022-07-12

Published Print: 2022-10

Authors

Qin, Yao

Shen, Kai

Pu, Jiaqi

Liu, Ting

Ma, Hongbing https://orcid.org/0000-0002-1174-4078
License Information

Text and Data Mining valid from 2022-07-12

Version of Record valid from 2022-07-12
More Information

Article History

Received: 1 June 2022

Accepted: 6 July 2022

First Online: 12 July 2022

Declarations

:

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

: Informed consent was obtained from the patient’s family.

: The authors declare no competing interests.

Document is current